SCHEMBL5698976

SCHEMBL5698976

NC(=NOCCCN1CCCCC1)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
MAPT P10636 5/20 0.53
POLB P06746 5/20 0.53
KMT2A Q03164 5/20 0.53
MEN1 O00255 4/20 0.53
CTDSP1 Q9GZU7 1/20 0.53
NPC1 O15118 4/20 0.47
RAB9A P51151 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C19 P33261 2/20 0.47
HTT P42858 1/20 0.47
LTA4H P09960 1/20 0.47
PTGS2 P35354 1/20 0.47
LMNA P02545 1/20 0.46
RAD52 P43351 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3055264 0.99 ALDH1A1 (0.53) ALDH1A1MAPTPOLBKMT2AMEN1
SCHEMBL3064563 0.87 POLB (0.50) ALDH1A1POLBKMT2AMEN1RAB9A
SCHEMBL3556745 0.87 POLB (0.50) ALDH1A1POLBKMT2AMEN1RAB9A
SCHEMBL3064562 0.87 POLB (0.50) ALDH1A1POLBKMT2AMEN1RAB9A
Hydrochloric Acid SCHEMBL3067119 0.86 POLB (0.49) ALDH1A1POLBKMT2AMEN1RAB9A
Hydrochloric Acid SCHEMBL3067120 0.86 POLB (0.49) ALDH1A1POLBKMT2AMEN1RAB9A
Hydrochloric Acid SCHEMBL7218972 0.86 POLB (0.49) ALDH1A1POLBKMT2AMEN1RAB9A
Hydrochloric Acid SCHEMBL3059893 0.79 ALDH1A1 (0.50) ALDH1A1KMT2A
SCHEMBL5698972 0.79 POLB (0.53) ALDH1A1MAPTPOLBKMT2AMEN1
Hydrochloric Acid SCHEMBL3055260 0.78 LMNA (0.54) ALDH1A1MAPTPOLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966283-B1 PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING DISEASES RESULTING FROM THE DAMAGING OF THE VASCULAR ENDOTHELIAL CELLS CYTRX CORP (US) 2006-06-14 EP disclosed
CN-1152871-C Hydroxylamine derivatives for enhancing the production of molecular chaperones and preparation thereof �ݰ��п�˹�о���չ��˾ 2004-06-09 CN disclosed
US-6143741-A TREATING OR PREVENTING ILLNESSES RESULTING FROM DAMAGED ENDOTHELIAL CELLS SUCH AS ATHEROSCLEROSIS, THROMBOSIS, RESTENOSIS, VESSEL SPASM BY ADMINISTERING HYDROXYLAMINE DERIVATIVE BIOREX Kutato es Fejleszo Rt. (HU) 2000-11-07 US disclosed
EP-0966283-A2 PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS BIOREX RT. (HU) 1999-12-29 EP disclosed
WO-1998006400-A2 PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS BIOREX KUTATÓ ÉS FEJLESZTO^' RT. (HU) 1998-02-19 WO disclosed